Skip to content

Airtraq Versus Fiberoptic for Awake Tracheal Intubation

Airtraq Versus Fiberoptic for Awake Tracheal Intubation : A Randomised Non-inferiority Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03539185
Enrollment
78
Registered
2018-05-29
Start date
2018-06-01
Completion date
2020-05-18
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intubation;Difficult, Awake Intubation, Airway Complication of Anesthesia

Keywords

Airtraq, Fiberoptic, Awake, Tracheal intubation, laryngeal nerve blocks, sedation, remifentanil

Brief summary

The airway management is a vital act in anesthesia. The gold standard technique for planned very difficult intubation is nasotracheal fiberoptic intubation. The success rate with this procedure is 98.8%. However, learning this technique is difficult and it's considered uncomfortable by patients and practitioners. The Airtraq® videolaryngoscope is commonly used for difficult orotracheal intubation. Cases of awake intubation by Airtraq® have been described. Furthermore, the French Society of Anesthesia-Resuscitation, in its last formalized expert recommendations (2017) on difficult intubation, proposes the use of video laryngoscopes as an alternative to the fiberoptic bronchoscope. We propose a non-inferiority study evaluating the use of Airtraq® for the realization of a awake intubation compared to the gold standard (fiberoptic bronchoscope). This prospective randomized study should include 78 patients in two groups. The purpose of this study is to improve the comfort of patient and practitioner during an awake tracheal intubation, to facilitate the learning of the technique.

Interventions

DEVICEVideolaryngoscope Airtraq

Awake orotracheal intubation with laryngeal nerve block and remifentanil sedation

Awake nasotracheal intubation with laryngeal nerve block and remifentanil sedation

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Non-inferiority trial. Alpha risk de 2,5%, Power 90 %

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Formal indication of awake intubation or patient with two criteria of difficult intubation and ventilation * Major patient * Patient able to understand oral and written information

Exclusion criteria

* Mouth opening (inter-incisor distance) \<16 mm does not allow insertion of the Airtraq® videolaryngoscope * Surgery requires nasotracheal intubation * Loco-regional anesthesia of larynx impossible

Design outcomes

Primary

MeasureTime frameDescription
Success of orotracheal or nasotracheal intubation.1 dayDefined by the visualization of the tube into the trachea through vocal cords and by the appearance of the capnogram

Secondary

MeasureTime frameDescription
Length of the proceedings1 dayDuration between the insertion of device and the appearance of capnogram
Rate of occurrence of adverse events1 dayCoughing, desaturation, agitation
Patient satisfaction score1 dayAnalogue visual scale graduated from zero to ten. Zero is the worst imaginable satisfaction and 10 is the better imaginable satisfaction.
Operator satisfaction score1 dayAnalogue visual scale graduated from zero to ten. Zero is the worst imaginable satisfaction and 10 is the better imaginable satisfaction.
Number of intubation attempts1 day

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026